Can you provide the last earnings date for HLS THERAPEUTICS INC?
HLS THERAPEUTICS INC (HLS.CA) last reported earnings on 3/12/2026.
TSX:HLS • CA40390B1094
Past quarterly earnings results for HLS THERAPEUTICS INC (HLS.CA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.12 | -0.07 | -69.73% | 20.00% | 13.511M | 14.468M | -6.61% | -4.08% |
| Q2 2025 | -0.09 | -0.07 | -27.30% | 50.00% | 14.171M | 14.645M | -3.24% | -2.40% |
| Q1 2025 | -0.14 | -0.12 | -16.97% | 26.32% | 12.623M | 12.645M | -0.17% | 1.20% |
| Q4 2024 | -0.10 | -0.09 | -11.88% | 41.18% | 15.542M | 15.857M | -1.99% | -2.02% |
| Q3 2024 | -0.15 | -0.15 | -2.42% | 28.57% | 14.085M | 14.948M | -5.77% | -12.17% |
| Q2 2024 | -0.18 | -0.18 | 0.99% | 37.93% | 14.519M | 14.504M | 0.10% | -11.56% |
| Q1 2024 | -0.19 | -0.19 | -1.69% | -5.56% | 12.473M | 14.706M | -15.18% | -15.48% |
| Q4 2023 | -0.17 | -0.10 | -77.18% | 15.00% | 15.863M | 16.615M | -4.53% | 1.17% |
| Q3 2023 | -0.21 | -0.10 | -118.86% | -50.00% | 16.037M | 16.438M | -2.44% | 2.15% |
| Q2 2023 | -0.29 | -0.13 | -129.70% | -107.14% | 16.417M | 16.009M | 2.55% | 5.71% |
| Q1 2023 | -0.18 | -0.12 | -54.97% | -63.64% | 14.757M | 15.756M | -6.34% | 1.35% |
| Q4 2022 | -0.20 | -0.07 | -170.04% | -53.85% | 15.68M | 17.173M | -8.69% | -0.06% |
| Q3 2022 | -0.14 | -0.13 | -3.96% | -133.33% | 15.7M | 16.749M | -6.26% | 4.25% |
| Q2 2022 | -0.14 | -0.08 | -84.82% | -100.00% | 15.53M | 16.747M | -7.27% | 3.88% |
| Q1 2022 | -0.11 | -0.10 | -6.25% | 26.67% | 14.56M | 15.739M | -7.49% | 1.75% |
| Q4 2021 | -0.13 | -0.10 | -28.71% | 48.00% | 15.69M | 16.896M | -7.14% | -4.85% |
| Q3 2021 | -0.06 | -0.11 | 45.99% | -20.00% | 15.06M | 16.046M | -6.14% | 14.70% |
| Q2 2021 | -0.07 | -0.15 | 53.80% | 65.00% | 14.95M | 14.948M | 0.01% | 18.56% |
| Q1 2021 | -0.15 | -0.15 | 3.14% | - | 14.31M | 15.016M | -4.70% | 3.02% |
| Q4 2020 | -0.25 | -0.07 | -280.81% | - | 16.49M | 16.367M | 0.75% | - |
| Q3 2020 | -0.05 | -0.15 | 65.86% | - | 13.13M | 13.374M | -1.82% | - |
| Q2 2020 | -0.20 | -0.14 | -46.68% | - | 12.61M | 13.821M | -8.76% | - |
| Q1 2020 | 0.00 | -0.20 | 100.00% | - | 13.89M | 12.995M | 6.89% | - |
Notes
HLS THERAPEUTICS INC (HLS.CA) last reported earnings on 3/12/2026.
HLS THERAPEUTICS INC (HLS.CA) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, HLS THERAPEUTICS INC (HLS.CA) has beaten EPS estimates in 0 out of 4 releases.